Southlake, TX, June 04, 2024 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced that on June 3, 2024, the Company received formal notice from the Listing Qualifications Staff of the Nasdaq Stock Market LLC indicating that HeartSciences has regained compliance with bid price requirement as set forth in Listing Rule 5550(a)(2), and that the Company is therefore in compliance with the Nasdaq Capital Market’s listing requirements and the scheduled hearing has now been cancelled.
Ryan El-Hosseiny Declares Elizabeth Holmes Was Right All Along—And Plans to Prove It Live! Just…
The Café SHEIN FW25 Pop-Up to Take Over Parramatta this MaySYDNEY, April 22, 2025 (GLOBE…
Used ag plastic jugs ready to be collected and recycled by Cleanfarms Farmers' efforts in…
BELMONT, CA, April 21, 2025 (GLOBE NEWSWIRE) -- Notre Dame de Namur University (NDNU), the…
According to Pixalate's research, 'My FitnessPal' ranked at the top on both Google Play Store…
According to Pixalate's research, ‘Gangstar Vegas: World of Crime’ on Google Play Store generated an…
This website uses cookies.